Evaluating the Relevance of Virtual Drugs - Bordeaux Population Health Accéder directement au contenu
Article Dans Une Revue Studies in Health Technology and Informatics Année : 2022

Evaluating the Relevance of Virtual Drugs

Résumé

Information about drugs is numerous and varied, and many drugs can share the same information. Grouping drugs that have common characteristics can be useful to avoid redundancy and facilitate interoperability. Our work focused on the evaluation of the relevance of classes allowing this type of grouping: the "Virtual Drug". Thus, in this paper, we describe the process of creating this class from the data of the French Public Drug Database, which is then evaluated against the codes of the Anatomical Therapeutic Chemical classification associated with the drugs. Our evaluation showed that 99.55% of the "Virtual Drug" classes have a good intra-class consistency.
Fichier principal
Vignette du fichier
BPH_IOSPress_2022_Awuklu.pdf (212.41 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03701275 , version 1 (01-07-2022)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Yvon K. Awuklu, Vianney Jouhet, Sebastien Cossin, Frantz Thiessard, Romain Griffier, et al.. Evaluating the Relevance of Virtual Drugs. Studies in Health Technology and Informatics, 2022, 294, pp.322-326. ⟨10.3233/shti220467⟩. ⟨hal-03701275⟩

Collections

INSERM U1219
26 Consultations
18 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More